<DOC>
	<DOCNO>NCT00002328</DOCNO>
	<brief_summary>To provide azithromycin treatment individual patient proven cryptosporidiosis whose disease persist progressed despite prior therapy .</brief_summary>
	<brief_title>Azithromycin Treatment Cryptosporidiosis Patients Who Have Not Had Success With Other Drugs</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Cryptosporidiosis</mesh_term>
	<criteria>Inclusion Criteria Patients must : Cryptosporidiosis infection . Life expectancy least 1 week . Failed intolerant prior therapy standard antidiarrheal antibiotic therapy cryptosporidiosis . Consent parent guardian patient legal age consent . Patients document favorable response azithromycin Pfizer protocol 066143 may receive maintenance therapy protocol . Patients persistent diarrhea require intravenous ( IV ) fluid therapy maintain hydration may receive IV azithromycin approval clinical monitor . Patients whose disease worsen despite minimum 2 week oral therapy patient whose disease show improvement 4 week oral therapy also consider trial period intravenous azithromycin . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Known hypersensitivity significant intolerance macrolide antibiotic . Eligibility current treatment medical center perform study 066143 , another study azithromycin treatment cryptosporidiosis AIDS patient . Required : Must fail intolerant prior therapy standard antidiarrheal antibiotic therapy cryptosporidiosis .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 1998</verification_date>
	<keyword>Antidiarrheals</keyword>
	<keyword>Cryptosporidiosis</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Azithromycin</keyword>
</DOC>